AU2010209650 (A1) Key intermed...42 从上述信息判断该文献的文献类型为：
举一反三
- AU2010209650(A1)KeyintermediatesforthesynthesisofRosuvastatinorpharmaceuticallyacceptablesaltsthereof.Inventor(s):ZDENKOCASARJANEZKOSMRLJ(CASAR,ZDENKO,KOSMRLJ,JANEZ)Applicant(s):LEKPHARMACEUTICALS(LEKPHARMACEUTICALSD.D)Classification:-international:A61K31/505A61P3/06C07D239/42-European:C07D239/42从上述信息判断该文献的文献类型为：
- AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：
- AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR JANEZ KOSMRLJ (CASAR, ZDENKO, KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505 A61P3/06 C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：
- 中国大学MOOC: AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为：
- 按文献信息的加工程度划分，文献信息类型可分为（ ）。 A: 一次文献 B: 二次文献 C: 三次文献 D: 四次文献